Apimeds Pharmaceuticals US, Inc.

Ownership Transactions Reported by 9 Insiders

Symbol
APUS on NYSE
Industry
Pharmaceutical Preparations
Location
2 East Broad Street, 2 Nd Floor, Hopewell, NJ

There are no Buy or Sell transactions made by insiders since 10/6/2024

Apimeds Pharmaceuticals US, Inc. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
Inscobee Inc. 10%+ Owner $5.46M May 12, 2025
Erik C. Emerson Chief Executive Officer, Director $1.31M May 16, 2025
Christopher Kim Chairman and CMO, Director $486K May 16, 2025
Carol O'donnell Director May 16, 2025
Bennett Weintraub Director May 16, 2025
Mark Corrao Chief Financial Officer Mar 4, 2025
Jakap Koo Director May 16, 2025
Elona Kogan Director May 16, 2025
Hankil Yoon Director May 16, 2025

Recent Insider Transactions by Companies or Individuals for Apimeds Pharmaceuticals US, Inc.

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.